What Are cGMPs for Dietary Supplements?

Direct answer

Current Good Manufacturing Practices (cGMP) for dietary supplements are the FDA regulations at 21 CFR Part 111. They govern how supplements are manufactured, packaged, labeled, and held. The “c” stands for Current: the practices must reflect current industry standards. cGMP applies to facilities, equipment, personnel, raw materials, production processes, and record-keeping.

FDA does not issue cGMP certificates. FDA registers facilities under the Food Facility Registration program, inspects facilities, and issues Form 483 observations or Warning Letters when it finds cGMP violations. A search of the FDA.gov resources in the Primary sources section below will not find any program through which FDA issues cGMP certificates to supplement manufacturers.

Third-party organizations (NSF, NPA, USP) operate separate cGMP registration programs with their own audits and certificates. Those programs are private-sector. They are real and widely recognized, but they are not “FDA certification.”

Three separate cGMP frameworks

Understanding which cGMP applies to your product prevents common confusion.

A manufacturer claiming “cGMP compliant” without specifying which cGMP is either confusingly broad or produces across categories. Ask which rule applies to their work on your specific product.

What 21 CFR Part 111 covers

Part 111 is organized by Subparts, each covering a specific area of supplement manufacturing. The authoritative current text is on eCFR; updates appear there before any third-party summary reflects them.

• Subpart A (General provisions): scope, definitions, and applicability (manufacturers, packagers, labelers, holders).
• Subpart B (Personnel): qualifications, training, hygiene, supervision.
• Subpart C (Physical plant and grounds): contamination prevention, sanitation, pest control, utility controls.
• Subpart D (Equipment and utensils): design, cleaning, calibration, and maintenance for every surface that touches the product.
• Subpart E (Production and process controls): identity testing on incoming raw materials, master manufacturing records, batch production records, in-process checks, finished-product testing. Operationally the heaviest Subpart.
• Subpart F (Quality unit requirements): the facility must have a designated quality unit with release-or-reject authority. Quality personnel cannot also run production on the same batch.
• Subpart G (Packaging and labeling operations): controls for packaging materials, label accuracy, and line operations.
• Subpart H (Holding and distribution): storage, inventory, traceability.
• Subpart I (Returned dietary supplements): return handling and reprocessing decisions.
• Subpart J (Product complaints): documentation and investigation of consumer complaints.
• Records and recordkeeping (later Subparts): retention, format, FDA access. Record retention generally runs through product expiration plus a retention window; check the specific Subparts on eCFR for the current rule text.

How to verify a manufacturer's cGMP status

1. FDA Food Facility Registration

All supplement manufacturers must register with FDA under the Food Facility Registration program. Ask for the facility's registration number and confirm registration is current. Registration is not the same as cGMP certification; it is an administrative filing.

2. Third-party GMP registration

Several non-governmental organizations operate supplement-GMP audit and registration programs:

• NSF/ANSI 173 dietary supplements standard. NSF International's supplement-specific standard; manufacturers can hold NSF GMP registration.
• Natural Products Association (NPA). Operates an NPA GMP registration program.
• U.S. Pharmacopeia (USP) Verification. A product-level verification program with finished-product testing and facility audit.

Ask for current certificates with expiration dates. Certifications are annual.

3. FDA Warning Letter history

Search the FDA Warning Letters database by facility name. A Warning Letter in the past two years warrants scrutiny: what did FDA cite, what remediation did the facility commit to, and what evidence do they have that the remediation is complete.

4. FDA inspection observations

FDA Form 483 observations are issued during inspections and are less severe than Warning Letters, but still meaningful. See FDA's inspection observations page for the framework. Some manufacturers share recent 483 history voluntarily in diligence.

5. On-site audit (for significant orders)

For larger orders or long-term supply relationships, an on-site facility audit by a qualified third-party firm (NSF, SGS, Eurofins, and others) is the most thorough check. Fees vary with facility size and audit scope. Request quotes directly from the audit firm for current pricing.

Common cGMP claim mistakes

“FDA-certified cGMP compliant.” FDA does not issue cGMP certificates. This wording is factually wrong and potentially deceptive. A supportable version: “FDA-registered facility, produced under 21 CFR Part 111 cGMP.”

“GMP-certified” without naming the certifier. If the certifier is NSF, write “NSF GMP-registered” or reference the specific standard (NSF/ANSI 173). If USP, write “USP Verified.” If there is no third-party certifier, write “operated under cGMP” without implying certification.

Claiming pharmaceutical-grade cGMP on supplement products. Pharmaceutical cGMP (21 CFR Parts 210/211) is stricter than supplement cGMP (21 CFR Part 111). A facility producing supplements is not pharmaceutical-grade unless separately qualified for drug production.

Using NSF or USP logos without active registration. Both organizations enforce trademark use. Unauthorized logo use is a legal exposure on top of a compliance exposure.

Red flags in manufacturer claims

• “GMP certified by FDA.” Factually wrong; FDA does not issue cGMP certificates.
• “Passed FDA inspection last quarter” without documentation. An inspection without issued 483 observations is plausible, but the burden is on the manufacturer to show specific documentation.
• “Our facility is cGMP compliant” without specifying which cGMP. Ask: 21 CFR Part 111, 21 CFR Part 117, or 21 CFR Parts 210/211? If they cannot answer, they do not fully understand which rule applies.
• No documented quality unit. Subpart F of Part 111 requires a designated quality unit with release authority. A facility without one cannot claim cGMP compliance.

Frequently asked questions